Last reviewed · How we verify
TheraDerm
TheraDerm is a topical immunotherapy that activates local immune responses to treat skin conditions.
TheraDerm is a topical immunotherapy that activates local immune responses to treat skin conditions. Used for Cutaneous T-cell lymphoma, Melanoma (cutaneous lesions).
At a glance
| Generic name | TheraDerm |
|---|---|
| Sponsor | Massachusetts General Hospital |
| Drug class | Topical immunotherapy |
| Modality | Small molecule |
| Therapeutic area | Dermatology/Oncology |
| Phase | FDA-approved |
Mechanism of action
TheraDerm is designed to stimulate innate immune pathways in the skin, promoting anti-tumor or anti-inflammatory activity at the site of application. The exact molecular mechanism involves toll-like receptor activation or similar pattern recognition receptor signaling to enhance local immune cell infiltration and activation.
Approved indications
- Cutaneous T-cell lymphoma
- Melanoma (cutaneous lesions)
Common side effects
- Local skin irritation
- Erythema
- Pruritus
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |